Haleos Labs Limited holds 20th AGM on Sep 30, 2026, approves dividend
Haleos Labs Limited conducted its 20th AGM on September 30, 2026, via video conference. Key approvals included the annual accounts for FY26, a 15% dividend for FY26, reappointment of directors and auditors. The company also discussed its name change, performance, and future outlook.
The AGM's outcomes, particularly the dividend declaration and director reappointments, have a direct impact on shareholders and corporate governance. The discussion on future outlook also provides insights into the company's strategic direction.
The meeting successfully transacted key business, including the approval of annual accounts and a dividend, indicating smooth operations and positive shareholder engagement.
Haleos Labs Limited (formerly SMS Lifesciences India Limited) held its 20th Annual General Meeting (AGM) on Wednesday, September 30, 2026, commencing at 3:00 PM and concluding at 4:10 PM, conducted via video conference. The meeting addressed several key business items as per the notice dated August 5, 2026.
Ordinary business transacted included the approval of the annual accounts for the year ended March 31, 2026, declaration of a 15% dividend for the financial year 2025-26, the reappointment of Mr. TWSN Murthy who was retiring by rotation, and the approval for the appointment of statutory auditors for a period of five years.
Special business included the approval of remuneration for the Cost Auditors for the year 2026-27, the re-appointment of Dr. Mannam Malakondaiah as Independent Director for a second term, the re-appointment of Dr. Srinivas Samavedam as Independent Director for a second term, and the approval for revision of remuneration for Mr. TWSN Murthy, the Managing Director.
The company provided e-voting facilities, with remote e-voting available from September 26 to September 29, 2026. Members who had not voted remotely were given the option to vote during the AGM. The Chairman, Mr. TWSN Murthy, addressed the shareholders, highlighting the reasons for the company's name change, its operational and financial performance during 2025-26, and its future outlook. The dividend, if passed, will be credited within 30 days of declaration, subject to TDS. Transcript and video recording of the AGM will be available on the company's website.
What to do with a filing like this
HALEOS LABS LIMITED filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by HALEOS LABS LIMITED. Read the original for the full detail.